Boardroom Alpha
Boardroom Alpha
BA · Additional Proxy Materials (DEFA14A) · Filed March 6, 2026

Boeing Co — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
March 6, 2026
Ticker
BA
Accession
0001193125-26-096837
Boardroom Alpha · Filing insights

The Boeing Company urges opposition to two shareholder proposals on disability access and written consent; backs the management slate.

About Boeing Co
Market cap
$171.6B
1Y TSR
+9.4%
3Y TSR
+2.1%
Board grade
C+
Sector
Industrials
CEO
Robert Kelly Ortberg
Last annual meeting: Apr 17, 2026 · View full Boeing Co profile →
DEFA14A
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

(Rule 14a-101)

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

Filed by the Registrant        Filed by a Party other than the Registrant 

Check the appropriate box:

 

Preliminary Proxy Statement

 

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

 

Definitive Proxy Statement

 

Definitive Additional Materials

 

Soliciting Material Pursuant to §240.14a-12


THE BOEING COMPANY

(Name of registrant as specified in its charter)


 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

 

No fee required

 

Fee paid previously with preliminary materials.

 

Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

 

 
 


LOGO

Your Vote Counts! THE BOEING COMPANY THE BOEING COMPANY 929 LONG BRIDGE DRIVE ARLINGTON, VA 22202 2026 Annual Meeting Vote by April 16, 2026 11:59 PM ET. V83094-P45267-Z91973 You invested in THE BOEING COMPANY and it’s time to vote! You have the right to vote on proposals being presented at the 2026 Annual Meeting of Shareholders. This is an important notice regarding the availability of proxy materials for the shareholder meeting to be held on April 17, 2026. Get informed before you vote View the Notice of The Boeing Company’s 2026 Annual Meeting of Shareholders, Proxy Statement and the 2025 Annual Report online OR you can receive a free paper or email copy of the material(s) by requesting prior to April 3, 2026. If you would like to request a copy of the material(s) for this and/or future shareholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. Requests, instructions and other inquiries sent to this email address will NOT be forwarded to your investment advisor. For complete information and to vote, visit www.ProxyVote.com Control # Smartphone users Vote Virtually at the Meeting* April 17, 2026 Point your camera here and 9:00 A.M. ET vote without entering a You must have the Control # from the control number box above to attend and vote at the Annual Meeting. www.virtualshareholdermeeting.com/BA2026 Before the meeting: Go to www.ProxyVote.com or scan the QR Barcode above using your smartphone. Have the 16 digit control number that is printed in the box above and follow the instructions. *Please check the meeting materials for any special requirements for meeting attendance.


LOGO

THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming shareholder meeting. Please follow the instructions on the reverse side to vote these important matters. Board Voting Items Recommends 1. Election of Directors Nominees: 1a. Robert A. Bradway For 1b. Mortimer “Tim” J. Buckley For 1c. Lynne M. Doughtie For 1d. David L. Gitlin For 1e. Lynn J. Good For 1f. Stayce D. Harris For 1g. Akhil Johri For 1h. David L. Joyce For 1i. Steven M. Mollenkopf For 1j. Robert Kelly Ortberg For 1k. John M. Richardson For 1l. Bradley D. Tilden For 2. Approve, on an Advisory Basis, Named Executive Officer Compensation. For 3. Ratify the Appointment of Deloitte & Touche LLP as Independent Auditor for 2026. For 4. Shareholder Proposal - Board Committee on Disability Access. Against 5. Shareholder Proposal - Action by Written Consent. Against NOTE: In their discretion, the proxies are authorized to vote on such other matters that may properly come before the 2026 Annual Meeting of Shareholders or any other adjournment or postponement thereof. Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”.


LOGO

Your Vote Counts! THE BOEING COMPANY 2026 Annual Meeting Vote by April 16, 2026 11:59 PM ET V83096-P45053 You invested in THE BOEING COMPANY and it’s time to vote! You have the right to vote on proposals being presented at the 2026 Annual Meeting of Shareholders. This is an important notice regarding the availability of proxy materials for the shareholder meeting to be held on April 17, 2026. Get informed before you vote View the Notice of The Boeing Company’s 2026 Annual Meeting of Shareholders, Proxy Statement and the 2025 Annual Report OR you can receive a free paper or email copy of the material(s) by requesting prior to April 3, 2026. If you would like to request a copy of the material(s) for this and/or future shareholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. Requests, instructions and other inquiries sent to this email address will NOT be forwarded to your investment advisor. For complete information and to vote, visit www.ProxyVote.com Control # Smartphone users Vote Virtually at the Meeting* April 17, 2026 Point your camera here and 9:00 A.M. ET vote without entering a You must have the Control # from the control number box above to attend and vote at the Annual Meeting. www.virtualshareholdermeeting.com/BA2026 Before the meeting: Go to www.ProxyVote.com or scan the QR Barcode above using your smartphone. Have the 16 digit control number that is printed in the box above and follow the instructions. *Please check the meeting materials for any special requirements for meeting attendance.


LOGO

Vote at www.ProxyVote.com THIS IS NOT A VOTABLE BALLOT THE BOEING COMPANY This is an overview of the proposals being presented at the 2026 Annual Meeting upcoming shareholder meeting. Please follow the instructions on Vote by April 16, 2026 the reverse side to vote these important matters. 11:59 PM ET Board Voting Items Recommends 1. Election of Directors Nominees: 1a. Robert A. Bradway For 1b. Mortimer “Tim” J. Buckley For 1c. Lynne M. Doughtie For 1d. David L. Gitlin For 1e. Lynn J. Good For 1f. Stayce D. Harris For 1g. Akhil Johri For 1h. David L. Joyce For 1i. Steven M. Mollenkopf For 1j. Robert Kelly Ortberg For 1k. John M. Richardson For 1l. Bradley D. Tilden For 2. Approve, on an Advisory Basis, Named Executive Officer Compensation. For 3. Ratify the Appointment of Deloitte & Touche LLP as Independent Auditor for 2026. For 4. Shareholder Proposal - Board Committee on Disability Access. Against 5. Shareholder Proposal - Action by Written Consent. Against NOTE: Such other business as may properly come before the meeting or any adjournment thereof.

From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Boeing Co (BA)

Reference

Frequently asked questions

When did Boeing Co file this DEFA14A?
Boeing Co (BA) filed this Additional Proxy Materials (DEFA14A) with the SEC on March 6, 2026. The accession number assigned by EDGAR is 0001193125-26-096837.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
The Boeing Company urges opposition to two shareholder proposals on disability access and written consent; backs the management slate. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
Where can I find Boeing Co's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Boeing Co has filed under CIK 12927, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer